A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-02: Deceptive Representations Involving the FDIC's Name or Logo or Deposit Insurance".
Sponsor

Full profile: /officials/W000817
Source: Congress.gov · FEC
Cosponsors (0)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
2026-04-13
Source: Congress.gov
Committee Activity
Currently in
- Senate Committee on Banking, Housing, and Urban AffairsReferred To · 2026-04-13
Previously
- Banking, Housing, and Urban Affairs CommitteeReferred To · 2026-04-13
Plain-English Summary
Congress is voting on whether to block a consumer protection rule that was supposed to prevent banks and financial companies from misleadingly using the FDIC's name or logo to trick people into thinking their deposits are insured when they're not. The rule was withdrawn by the Consumer Financial Protection Bureau, and this resolution would formally disapprove of that withdrawal, essentially trying to keep the consumer protection in place. This affects everyday people who use banks and financial services, as well as the financial institutions themselves.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Full Bill Text
Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S.J. Res. 175 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. J. RES. 175 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to ``Consumer Financial Protection Circular 2022-02: Deceptive Representations Involving the FDIC's Name or Logo or Deposit Insurance''. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES April 13, 2026 Ms. Warren introduced the following joint resolution; which was read twice and referred to the Committee on Banking, Housing, and Urban Affairs _______________________________________________________________________ JOINT RESOLUTION Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to ``Consumer Financial Protection Circular 2022-02: Deceptive Representations Involving the FDIC's Name or Logo or Deposit Insurance''. Resolved by the Senate and House of Representatives of the United States of America in Congress assembled, That Congress disapproves the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to ``Consumer Financial Protection Circular 2022-02: Deceptive Representations Involving the FDIC's Name or Logo or Deposit Insurance (87 Fed. Reg. 35866 (June 14, 2022))'' (90 Fed. Reg. 20084 (May 12, 2025)), and such rule shall have no force or effect. <all>
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S4986Mamas First ActReferred to Committee · 2026-07-15
- S4987A bill to require the Federal Trade Commission to submit a report on foreign investment in the pharmaceutical industry of the United States, and for other purposes.Referred to Committee · 2026-07-15
- S4946Health and Location Data Protection Act of 2026Referred to Committee · 2026-07-13
- S4734Critical Defense Ownership Review ActReferred to Committee · 2026-06-10